Literature DB >> 11807153

Empirical antifungal therapy--new options, new tradeoffs.

Kieren A Marr.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11807153     DOI： 10.1056/NEJM200201243460410

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea.

Authors:  K Moeremans; L Annemans; Ji-So Ryu; Kang-Won Choe; Wan-Shik Shine
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

2.  Risk-adapted strategy for the management of febrile neutropenia in cancer patients.

Authors:  Jean Klastersky; Marianne Paesmans
Journal:  Support Care Cancer       Date:  2007-02-09       Impact factor: 3.603

3.  In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.

Authors:  M Drago; M M Scaltrito; G Morace
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-16       Impact factor: 3.267

4.  Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.

Authors:  A L Colombo; J Perfect; M DiNubile; K Bartizal; M Motyl; P Hicks; R Lupinacci; C Sable; N Kartsonis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-23       Impact factor: 3.267

Review 5.  Patients at high risk of invasive fungal infections: when and how to treat.

Authors:  Maria J G T Rüping; Jörg J Vehreschild; Oliver A Cornely
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.

Authors:  Sun Hee Park; Su-Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Jin-Hong Yoo; Woo-Sung Min; Wan-Shik Shin
Journal:  Korean J Intern Med       Date:  2006-09       Impact factor: 2.884

7.  Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature.

Authors:  Toufik Mahfood Haddad; Mahesh Anantha Narayanan; Krista E Shaw; Renuga Vivekanandan
Journal:  Case Rep Infect Dis       Date:  2015-08-24

8.  Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.

Authors:  Hideo Koh; Masayuki Hino; Kensuke Ohta; Masaki Iino; Fumiaki Urase; Masaki Yamaguchi; Jun Yamanouchi; Noriko Usui; Minoru Yoshida; Mitsune Tanimoto; Kazuma Ohyashiki; Akio Urabe; Kazuo Tamura; Akihisa Kanamaru; Tohru Masaoka
Journal:  J Infect Chemother       Date:  2013-06-28       Impact factor: 2.211

Review 9.  Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1).

Authors:  Hamdi Akan; Seniz Ongören Aydın; Neşe Saltoğlu; Atahan Cağatay; Halis Akalın; Mutlu Arat; Rıdvan Ali; Sevgi Kalayoğlu-Beşışık; A Muzaffer Demir
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

Review 10.  How to manage aspergillosis in non-neutropenic intensive care unit patients.

Authors:  Matteo Bassetti; Elda Righi; Gennaro De Pascale; Raffaele De Gaudio; Antonino Giarratano; Tereesita Mazzei; Giulia Morace; Nicola Petrosillo; Stefania Stefani; Massimo Antonelli
Journal:  Crit Care       Date:  2014-07-25       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.